submit news    HOME | FEEDBACK  


« NAVIGATION »
NEWS

- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials

- MEMS

- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software
COMPANIES
EVENTS

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events
FEEDBACK
ADVERTISE
LINK TO US

« PARTNERS »
Become A Nanotechwire Partner

FEI Company

Veeco Instruments

NanoDynamics

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here
« NEWSLETTER »



« SEARCH »







6/25/2006 10:29:07 AM
Sugar-Based Nanoparticles Have Potential to Deliver Proteins Orally

Nanotechnology-based drug delivery research has largely focused on developing nanoparticles for use with drugs that are poorly soluble in water with many notable successes. Now, a team of investigators at the University of Santiago de Compostela in Spain has used two different sugars to create a nanoparticle that can entrap water-soluble molecules such as proteins. The researchers believe that this nanoparticle could be used to create protein drug formulations that can be taken by mouth rather than by injection or inhalation. The results of this study were published in the journal Macromolecules.

Maria Alonso, Ph.D., and colleagues used the water-soluble sugar polymers, or polysaccharides, known as chitosan (CS) and glucomannan (GM) to create the new nanoparticles. Chitosan, obtained from insect shells, is used primarily as a plant growth enhancer, while glucomannan, a plant root product, is a soluble fiber used to treat constipation and high cholesterol. By varying the relative amounts of the two polysaccharides, the researchers were able to create stable nanoparticles that could efficiently entrap proteins. Additional experiments using different forms of glucomannan and a crosslinking agent provided data that should enable the fine-tuning of the release rates of proteins from the nanoparticles.

This work is described in a paper titled, “Formation of new glucomannan-chitosan nanoparticles and study of their ability to associate and deliver proteins.” An investigator from Cantabria Pharmaceuticals in Madrid, Spain, also participated in this study. An abstract of this paper is available at the journal’s website.

http://pubs.acs.org/cgi-bin/abstract.cgi/mamobx/2006/39/i12/abs/ma060230j.html.

Other Headlines from NCI Alliance for Nanotechnology in Cancer ...
 - Lab-on-a-Chip Platform Performs Molecular Dissection of Single Brain Tumor Cells
 - Porous Silica Nanoparticles Deliver Anticancer Therapy
 - Surprise Finding When Humble Protein and Nanoparticles Tag-Team to Kill Cancer Cells
 - Nanosensors Detect Signs of Cancer in Human Breath
 - Improving Cisplatin with Nanoparticles

More Drug Delivery Headlines ...
 - Medicine reaches the target with the help of magnets
 - Porous Silica Nanoparticles Deliver Anticancer Therapy
 - Surprise Finding When Humble Protein and Nanoparticles Tag-Team to Kill Cancer Cells
 - Improving Cisplatin with Nanoparticles
 - A pharmacy on the back of a cell


« Back To List »

« GET LISTED »
- submit company
- submit news
- submit events
- advertise here

« EVENTS »
Symposium on Ultra Clean Processing of Semiconductor Surfaces (UCPSS)
The purpose of the UCPSS symposium to increase the level of understanding on ultra-clean processing technology in all steps of the IC-production, PV and bioelectronics.

9TH International Symposium on Scanning Probe Microscopy & Optical Tweezers in Life Sciences
JOINT MEETING 2010 - A forum for applications in scanning probe and optical tweezers technologies in life sciences.

Nanomedicine: Reality Now and Soon - ESF-UB Conference in Biomedicine
This conference aims to provide detailed understanding and discuss the clinical utility of those areas of nanomedicine which are close to application or already clinically applied/on the market.

- More Events


Copyright © 2010 Nanotechwire.com | Privacy Policy |